🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $SWBI and executed a BUY strategy, securing a +116.95% net profit.

UPGRADE TO SEE LIVE SIGNALS

$BIM.PA

BioMerieux

European UnionEUROPEAN UNION
FREE PREVIEW
📅 Next Earnings: Jul 28, 2026 🌙 Close🌐 Website🏛️ Euronext Paris📁 Health Technology🏭 Medical Specialties
AVG HISTORICAL GAP-1.75%
MAX GAP RECORD-1.75%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY1.8%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. It develops testing, detection, and other laboratory system for the analysis of cancer, diseases, and infections caused by bacteria, virus, and fungi. The company was founded Alain Mérieux in 1963 and is headquartered in Marcy l'Etoile, France. Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL